Renal Denervation Ameliorates Atrial Remodeling in Type 2 Diabetic Rats by Regulating Mitochondrial Dynamics

Overview

Journal J Physiol Biochem

Specialties Biochemistry
Physiology

Date 2024 Oct 22

PMID 39436584

Authors

Jun-Yu Huo

Can Hou

Xiao-Long Li

Ling Yang

Wan-Ying Jiang

Affiliations

Soon will be listed here.

Abstract

There is no effective treatment for diabetes-related atrial remodeling currently. This study aimed to investigate the effects of renal denervation (RDN) on diabetes-related atrial remodeling and explore the related mechanisms. A type 2 diabetes mellitus model was established by high-fat diet feeding and low-dose streptozotocin injection in Sprague‒Dawley rats. After successful modeling, the diabetic rats were randomly assigned to two groups according to whether they were subjected to RDN or sham RDN surgery. At the end of the experiment, cardiac function and structure were evaluated by echocardiography and histology, respectively. Mitochondrial morphology, function and mitochondrial dynamics were assessed by multiple methods. Mdivi1 was used to verify the mechanism by which RDN improves atrial remodeling. In the 10th week, diabetic rats exhibited obvious atrial remodeling, including atrial enlargement and diastolic dysfunction. Pathological staining showed that diabetic rats had cardiomyocyte hypertrophy and interstitial fibrosis in atrial tissues. In terms of mitochondrial morphology and function, diabetic rats exhibited fragmented mitochondria, reduced adenosine triphosphate production and decreased mitochondrial membrane potential levels. Abnormal mitochondrial dynamics in diabetic rats were characterized by the inhibition of mitochondrial fusion, excessive mitochondrial fission, and the suppression of mitophagy. However, RDN effectively ameliorated diabetes-induced pathological atrial remodeling. In addition, RDN significantly improved mitochondrial morphological and functional abnormalities and corrected the disorders of mitochondrial dynamics. Furthermore, the protective effects of RDN against atrial remodeling were related to the regulation of mitochondrial dynamics. RDN prevented diabetes-induced atrial remodeling. These protective effects might be related to improvements in mitochondrial dynamics.

Citing Articles

Editorial Special Issue: 2022 consortium for trans-pyrenean investigations on obesity and diabetes.

Milagro F, Capel F, Lorente-Cebrian S J Physiol Biochem. 2024; 80(3):599-601.

PMID: 39327394 DOI: 10.1007/s13105-024-01051-w.

References

Mata R, Flores-Bocanegra L, Ovalle-Magallanes B, Figueroa M . Natural products from plants targeting key enzymes for the future development of antidiabetic agents. Nat Prod Rep. 2023; 40(7):1198-1249. DOI: 10.1039/d3np00007a. View

Ali M, Pearson-Stuttard J, Selvin E, Gregg E . Interpreting global trends in type 2 diabetes complications and mortality. Diabetologia. 2021; 65(1):3-13. PMC: 8660730. DOI: 10.1007/s00125-021-05585-2. View

Arnautu D, Arnautu S, Tomescu M, Luca S, Luca C . Increased Left Atrial Stiffness is Significantly Associated with Paroxysmal Atrial Fibrillation in Diabetic Patients. Diabetes Metab Syndr Obes. 2023; 16:2077-2087. PMC: 10349582. DOI: 10.2147/DMSO.S417675. View

Tadic M, Ilic S, Cuspidi C, Ivanovic B, Bukarica L, Kostic N . Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. Int J Cardiovasc Imaging. 2014; 31(1):65-76. DOI: 10.1007/s10554-014-0536-3. View

Tadic M, Vukomanovic V, Cuspidi C, Suzic-Lazic J, Stanisavljevic D, Celic V . Left atrial phasic function and heart rate variability in asymptomatic diabetic patients. Acta Diabetol. 2017; 54(3):301-308. DOI: 10.1007/s00592-016-0962-x. View

Tadic M, Cuspidi C . Left atrial function in diabetes: does it help?. Acta Diabetol. 2020; 58(2):131-137. DOI: 10.1007/s00592-020-01557-x. View

Wang A, Green J, Halperin J, Piccini Sr J . Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(8):1107-1115. DOI: 10.1016/j.jacc.2019.07.020. View

Quiles J, Gustafsson A . The role of mitochondrial fission in cardiovascular health and disease. Nat Rev Cardiol. 2022; 19(11):723-736. PMC: 10584015. DOI: 10.1038/s41569-022-00703-y. View

Wu Q, Zheng D, Liu P, Yang H, Li L, Kuang S . High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy. Cell Death Dis. 2021; 12(2):216. PMC: 7910592. DOI: 10.1038/s41419-021-03502-4. View

10.

Hu L, Ding M, Tang D, Gao E, Li C, Wang K . Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy. Theranostics. 2019; 9(13):3687-3706. PMC: 6587356. DOI: 10.7150/thno.33684. View

11.

Montaigne D, Marechal X, Coisne A, Debry N, Modine T, Fayad G . Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients. Circulation. 2014; 130(7):554-64. DOI: 10.1161/CIRCULATIONAHA.113.008476. View

12.

Azizi M, Saxena M, Wang Y, Jenkins J, Devireddy C, Rader F . Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. JAMA. 2023; 329(8):651-661. PMC: 9975904. DOI: 10.1001/jama.2023.0713. View

13.

Polhemus D, Trivedi R, Gao J, Li Z, Scarborough A, Goodchild T . Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney. J Am Coll Cardiol. 2017; 70(17):2139-2153. DOI: 10.1016/j.jacc.2017.08.056. View

14.

Bohm M, Ewen S, Wolf M . Renal Denervation Halts Left Ventricular Remodeling and Dysfunction in Heart Failure: New Shores Ahead. J Am Coll Cardiol. 2018; 72(21):2622-2624. DOI: 10.1016/j.jacc.2018.09.027. View

15.

Tahir E, Koops A, Warncke M, Starekova J, Neumann J, Waldeyer C . Effect of renal denervation procedure on left ventricular mass, myocardial strain and diastolic function by CMR on a 12-month follow-up. Jpn J Radiol. 2019; 37(9):642-650. DOI: 10.1007/s11604-019-00854-y. View

16.

Huo J, Jiang W, Zhang S, Lyu Y, Geng J, Chen M . Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression. Lab Invest. 2021; 102(4):341-351. DOI: 10.1038/s41374-021-00696-1. View

17.

Lackner L, Nunnari J . Small molecule inhibitors of mitochondrial division: tools that translate basic biological research into medicine. Chem Biol. 2010; 17(6):578-83. PMC: 2903962. DOI: 10.1016/j.chembiol.2010.05.016. View

18.

Maneechote C, Kerdphoo S, Jaiwongkam T, Chattipakorn S, Chattipakorn N . Chronic Pharmacological Modulation of Mitochondrial Dynamics Alleviates Prediabetes-Induced Myocardial Ischemia-Reperfusion Injury by Preventing Mitochondrial Dysfunction and Programmed Apoptosis. Cardiovasc Drugs Ther. 2021; 37(1):89-105. DOI: 10.1007/s10557-021-07250-7. View

19.

Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z . Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2019; 18(1):165. PMC: 6882319. DOI: 10.1186/s12933-019-0964-4. View

20.

He W, Liu H, Hu L, Wang Y, Huang L, Liang A . Icariin improves testicular dysfunction via enhancing proliferation and inhibiting mitochondria-dependent apoptosis pathway in high-fat diet and streptozotocin-induced diabetic rats. Reprod Biol Endocrinol. 2021; 19(1):168. PMC: 8576896. DOI: 10.1186/s12958-021-00851-9. View